New
Anji Pharmaceuticals
The AI engine Fit Assessment
BetaThe company demonstrates pharma tech activity by owning a patent related to biguanide compositions and metabolic disorder treatment, indicating focus on pharmaceutical research and development. Check Source
Blurb
Anji Pharmaceuticals is focused on tackling high-value targets validated by human genetics.
HQ Location
Cambridge (United States)
Founded
2018
Employees
1 - 10
Total funding raised
$105.00M
Funding Status
Series B, $70.00M, September 28, 2021
Anji Pharma is a global pharmaceutical company focused on tackling high-value targets validated by human genetics. We are exhaustive in our discovery and clinical efforts while nimble in our strategy and execution. We have assembled a world-class team of scientist entrepreneurs who are committed to accelerate innovative medicines worldwide.